Product information and disease descriptionPlace of product in therapyDisease description
Definition and etiology
5 evidence topics · 5 sources
Definition: autoantibody-mediated disorder of neuromuscular transmission
“Myasthenia gravis (MG) is an autoimmune neurological disorder characterized by defective transmission at the neuromuscular junction.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“MG is considered a classic example of antibody-mediated autoimmune disease.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“These autoantibodies disrupt cholinergic transmission between nerve terminals and muscle fibers by causing downregulation, destruction, functional blocking of AChRs, or disrupting the clustering of AChRs in the postsynaptic membrane.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Myasthenia gravis (MG) is an autoimmune disease caused by antibodies against the acetylcholine receptor (AChR), muscle-specific kinase (MuSK) or other AChR-related proteins in the postsynaptic muscle membrane.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Localized or general muscle weakness is the predominant symptom and is induced by the antibodies.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Patients are grouped according to the presence of antibodies, symptoms, age at onset and thymus pathology.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Generalized and ocular forms
“MG presents in two forms: ocular (oMG), affecting the levator palpebrae superioris, orbicularis oculi, and extraocular muscles, and generalized (gMG), involving bulbar, axial, limb, and respiratory muscles” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Most patients have generalized weakness affecting the extraocular, bulbar, trunk, and extremity muscles.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“In 20% of MG patients, the muscle weakness remains confined to the extraocular muscles” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“It is the prototypic autoimmune disease most commonly caused by antibodies to the acetylcholine receptor (AChR) leading to characteristic fatigable weakness of the ocular, bulbar, respiratory, axial, and limb muscles.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Etiology: autoantibody subgroups
“Antibodies against the AChR are found in approximately 80% of MG patients.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“AChR antibodies are predominantly of the IgG1 and IgG3 subclasses” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Antibodies against MuSK are found in approximately 7–10% of all MG patients and up to 40% of patients with generalized MG who are seronegative for AChR Abs.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Lrp4 antibodies are present in 2–50% of double seronegative MG cases” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“In around 10% of patients with generalized MG, no antibodies are detected by standard testing.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Many of these patients have low‐concentration or low‐affinity AChR antibodies when tested with more sensitive methods” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Etiology: thymus pathology and age at onset
“Most MG patients have pathogenic autoantibodies against the extracellular part of acetylcholine receptors (AChR), commonly associated with an abnormal thymus.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Thymoma is present in 10% of such patients, and thymic hyperplasia with ectopic germinal centers appears in most patients with symptom onset before age 50 years” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Early-onset MG (EOMG) corresponds to patients presenting before age 50.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Late-onset MG (LOMG) is defined by onset after the age of 50.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“MG is the most common paraneoplastic disorder associated with thymoma.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Conversely, 10–20% of patients with MG have thymomas” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Etiology: genetic susceptibility
“There is frequent association of A1-B8-DR3 haplotype with early-onset MG” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“A large genome-wide association study involving patients from North America and Italy identified different haplotypes across the HLA region, cytotoxic T-lymphocyte-associated protein 4 gene (CTLA4) and tumor necrosis factor receptor 4 superfamily, member 11a, (TNFRSF11A) and NFκB activator genes in early- and late-onset MG cases” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote